Efficacy and safety of the mosquitocidal drug ivermectin to prevent malaria transmission after treatment: a double-blind, randomized, clinical trial.
暂无分享,去创建一个
Teun Bousema | Hannah C. Slater | Kevin C Kobylinski | André Lin Ouédraogo | Chris Drakeley | T. Bousema | Kevin C. Kobylinski | C. Drakeley | S. Sirima | R. Sauerwein | W. Guelbéogo | K. Lanke | T. Churcher | Thomas S Churcher | A. Ouédraogo | Edith C. Bougouma | Alfred B Tiono | Alphonse Ouédraogo | Edith C Bougouma | Hannah C Slater | Robert W Sauerwein | Wamdaogo M Guelbéogo | Guido J H Bastiaens | Sodiomon B Sirima | Aïssata Barry | Issa Nebie | Maurice San Ouattara | Kjerstin H W Lanke | Lawrence Fleckenstein | A. Tiono | L. Fleckenstein | A. Ouédraogo | G. Bastiaens | Aissata Barry | H. Slater | Maurice S. Ouattara | I. Nebie’
[1] G. K. Jain,et al. Determination of lumefantrine in rat plasma by liquid-liquid extraction using LC-MS/MS with electrospray ionization: assay development, validation and application to a pharmacokinetic study. , 2009, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[2] Steven Edward Kern,et al. The effect of food consumption on lumefantrine bioavailability in African children receiving artemether–lumefantrine crushed or dispersible tablets (Coartem®) for acute uncomplicated Plasmodium falciparum malaria , 2010, Tropical medicine & international health : TM & IH.
[3] R. Hohl,et al. Orange juice decreases the oral bioavailability of ivermectin in healthy volunteers , 2003 .
[4] L. Ranford-Cartwright,et al. A real-time PCR assay for quantifying Plasmodium falciparum infections in the mosquito vector. , 2004, International journal for parasitology.
[5] L. Okell,et al. Malaria transmission after artemether-lumefantrine and dihydroartemisinin-piperaquine: a randomized trial. , 2013, The Journal of infectious diseases.
[6] S. Lindsay,et al. Duration of the mosquitocidal effect of ivermectin , 2012 .
[7] Annette Olsen,et al. Efficacy and safety of drug combinations in the treatment of schistosomiasis, soil-transmitted helminthiasis, lymphatic filariasis and onchocerciasis. , 2007, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[8] M. Boussinesq,et al. Serious reactions after mass treatment of onchocerciasis with ivermectin in an area endemic for Loa loa infection , 1997, The Lancet.
[9] T. Bousema,et al. Single dose primaquine for clearance of Plasmodium falciparum gametocytes in children with uncomplicated malaria in Uganda: a randomised, controlled, double-blind, dose-ranging trial. , 2014, The Lancet. Infectious diseases.
[10] T. Bousema,et al. A protocol for membrane feeding assays to determine the infectiousness of P. falciparum naturally infected individuals to Anopheles gambiae , 2013 .
[11] Safety, Tolerability, and Pharmacokinetics of Escalating High Doses of Ivermectin in Healthy Adult Subjects , 2002, Journal of clinical pharmacology.
[12] D. Schmatz,et al. Drug-resistant Drosophila indicate glutamate-gated chloride channels are targets for the antiparasitics nodulisporic acid and ivermectin. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[13] Kevin C. Kobylinski,et al. Ivermectin mass drug administration to humans disrupts malaria parasite transmission in Senegalese villages. , 2011, The American journal of tropical medicine and hygiene.
[14] Teun Bousema,et al. The potential impact of adding ivermectin to a mass treatment intervention to reduce malaria transmission: a modelling study. , 2014, The Journal of infectious diseases.
[15] Shen Wei,et al. Liquid chromatographic assay of ivermectin in human plasma for application to clinical pharmacokinetic studies. , 2006, Journal of pharmaceutical and biomedical analysis.
[16] The effect of echinacea on CYP3A activity in vivo , 2003 .
[17] T. Wellems,et al. The threat of artemisinin-resistant malaria. , 2011, The New England journal of medicine.
[18] Q. Bassat,et al. Ivermectin to reduce malaria transmission: a research agenda for a promising new tool for elimination , 2013, Malaria Journal.
[19] Kevin C. Kobylinski,et al. Mass drug administration of ivermectin in south-eastern Senegal reduces the survivorship of wild-caught, blood fed malaria vectors , 2010, Malaria Journal.
[20] N. White. Primaquine to prevent transmission of falciparum malaria. , 2013, The Lancet. Infectious diseases.
[21] O. Müller,et al. Strong Gametocytocidal Effect of Methylene Blue-Based Combination Therapy against Falciparum Malaria: A Randomised Controlled Trial , 2009, PloS one.
[22] O. Doumbo,et al. Mosquito Feeding Assays to Determine the Infectiousness of Naturally Infected Plasmodium falciparum Gametocyte Carriers , 2012, PloS one.
[23] J. Lines,et al. Effect of ivermectin on Anopheles gambiae mosquitoes fed on humans: the potential of oral insecticides in malaria control. , 2010, The Journal of infectious diseases.
[24] N. Opoku,et al. The chemotherapy of onchocerciasis. XIX: The clinical and laboratory tolerance of high dose ivermectin. , 1995, Tropical medicine and parasitology : official organ of Deutsche Tropenmedizinische Gesellschaft and of Deutsche Gesellschaft fur Technische Zusammenarbeit.
[25] T. Geary,et al. Ivermectin distribution in the plasma and tissues of patients infected with Onchocerca volvulus , 1996, European Journal of Clinical Pharmacology.
[26] T. Bousema,et al. The relevance and applicability of oocyst prevalence as a read-out for mosquito feeding assays , 2013, Scientific Reports.
[27] J. Meis,et al. A scanning electron microscopic study of the sporogonic development of Plasmodium falciparum in Anopheles stephensi. , 1992, Acta tropica.
[28] K. Silamut,et al. Artemisinin resistance in Plasmodium falciparum malaria. , 2009, The New England journal of medicine.